Sean D. Buckley
Chief Tech/Sci/R&D Officer bei IMMUNOCORE HOLDINGS PLC
Profil
Sean D.
Buckley is currently the Chief Information Officer & VP at Immunocore Holdings Plc.
Previously, he held positions as the Manager-Information Technology at Toray Advanced Composites UK Ltd., the Chief Financial Officer & Vice President at Fibrocell Science, Inc., the Chief Financial Officer & Senior Vice President at Carmell Corp., and the Chief Business Officer & Vice President at Castle Creek Biosciences, Inc. He obtained an undergraduate degree from The University of Hull and an MBA from the Robert H.
Smith School of Business.
Aktive Positionen von Sean D. Buckley
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNOCORE HOLDINGS PLC | Chief Tech/Sci/R&D Officer | 01.09.2021 |
Ehemalige bekannte Positionen von Sean D. Buckley
| Unternehmen | Position | Ende |
|---|---|---|
| CARMELL CORPORATION | Director of Finance/CFO | 01.09.2022 |
Castle Creek Biosciences, Inc.
 Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | Corporate Officer/Principal | 01.01.2021 |
| FIBROCELL SCIENCE, INC. | Director of Finance/CFO | 01.12.2019 |
Toray Advanced Composites UK Ltd.
 Toray Advanced Composites UK Ltd. Chemicals: SpecialtyProcess Industries Toray Advanced Composites UK Ltd. engages in the manufacture and marketing of thermoset prepregs for aerospace and industrial markets. The company was founded on June 27, 1988 and is headquartered in Nottingham, the United Kingdom. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Sean D. Buckley
| The University of Hull | Undergraduate Degree |
| Robert H. Smith School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| IMMUNOCORE HOLDINGS PLC | Health Technology |
| CARMELL CORPORATION | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Fibrocell Science, Inc.
 Fibrocell Science, Inc. Pharmaceuticals: MajorHealth Technology Fibrocell Science, Inc. is an autologous cell and gene therapy company, which focuses on translating personalized biologics into medical breakthroughs for diseases affecting the skin and connective tissue. The company was founded on December 28, 1995 and is headquartered in Exton, PA. | Health Technology |
Toray Advanced Composites UK Ltd.
Toray Advanced Composites UK Ltd. Chemicals: SpecialtyProcess Industries Toray Advanced Composites UK Ltd. engages in the manufacture and marketing of thermoset prepregs for aerospace and industrial markets. The company was founded on June 27, 1988 and is headquartered in Nottingham, the United Kingdom. | Process Industries |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | Health Technology |
